Search - tctmd.com

Displaying 141 - 160 of 166

Sort: Relevancy | Date

News Industry News

Boston Scientific Reports Favorable Six-Month Results from Lotus™ Valve System Clinical Trial

September 17, 2013

Presentation EuroPCR 2013

Repositionable Percutaneous Replacement of a Stenotic Aortic Valve through Implantation of the Lotus Valve System

Presenter: 203171|Ian Meredith

May 31, 2013

Presentation EuroPCR 2013

First Report of One-Year Outcomes of the REPRISE I Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System

Presenter: 203171|Ian Meredith

May 31, 2013

News Industry News

Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial

May 22, 2013

News Industry News

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

May 17, 2013

Presentation ACC 2013

The Repositionable Lotus Aortic Valve Replacement System: Six-Month Outcomes in the REPRISE I Feasibility Study

Presenter: Ian T. Meredith

March 11, 2013

Presentation TCT 2013

Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Presenter: Ian Meredith, Stephen Worthley, Robert Whitbourn, Paul Antonis, Joseph Montarello, Andrew Newcomb, Dominic Allocco, Keith Dawkins

January 31, 2013

News Daily News

Registro Europeo: Los Dispositivos TAVR revelan Resultados Similares a Corto y Largo Plazo

Caitlin E. Cox

January 16, 2013

News Daily News

European Registry: TAVR Devices Show Similar Short-, Long-term Outcomes

Caitlin E. Cox

January 16, 2013

Presentation ICI 2012

The Lotus Valve Clinical Programme

Presenter: B. Chevalier

December 02, 2012

Presentation TCT 2012

Boston Scientific Sadra Lotus TAVR System

Presenter: Ian Meredith

October 24, 2012

Presentation TCT 2012

TCT-104. Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Presenter: Ian Meredith

October 23, 2012

News Industry News

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

October 23, 2012

News Industry News

First Patient Enrolled in REPRISE II TAVR Clinical Trial to Evaluate the Safety and Performance of the Lotus™ Valve System

October 10, 2012

Presentation EuroPCR 2012

Repositionable Percutaneous Replacement of a Stenotic Aortic Valve through Implantation of the Lotus Valve System

Presenter: 203171|Ian Meredith

May 18, 2012

News Industry News

Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial

May 15, 2012

News Industry News

Boston Scientific Completes Enrollment in Clinical Trial to Evaluate Lotus™ Aortic Valve System

April 23, 2012

News Conference News

Next-Generation Devices Address Complications of TAVR

November 08, 2011

News Industry News

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

November 01, 2011

Partner Content

ACURATE neo, LOTUS Edge, and Sentinel CPS: Advancing Safety for TAVR Patients - Boston Scientific

November 4, 2019

Advertisement

Boston Scientific Reports Favorable Six-Month Results from Lotus™ Valve System Clinical Trial

Repositionable Percutaneous Replacement of a Stenotic Aortic Valve through Implantation of the Lotus Valve System

First Report of One-Year Outcomes of the REPRISE I Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System

Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

The Repositionable Lotus Aortic Valve Replacement System: Six-Month Outcomes in the REPRISE I Feasibility Study

Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Registro Europeo: Los Dispositivos TAVR revelan Resultados Similares a Corto y Largo Plazo

European Registry: TAVR Devices Show Similar Short-, Long-term Outcomes

The Lotus Valve Clinical Programme

Boston Scientific Sadra Lotus TAVR System

TCT-104. Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

First Patient Enrolled in REPRISE II TAVR Clinical Trial to Evaluate the Safety and Performance of the Lotus™ Valve System

Repositionable Percutaneous Replacement of a Stenotic Aortic Valve through Implantation of the Lotus Valve System

Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial

Boston Scientific Completes Enrollment in Clinical Trial to Evaluate Lotus™ Aortic Valve System

Next-Generation Devices Address Complications of TAVR

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

ACURATE neo, LOTUS Edge, and Sentinel CPS: Advancing Safety for TAVR Patients - Boston Scientific

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content